Jianjun Lv

1.8k total citations
28 papers, 1.4k citations indexed

About

Jianjun Lv is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Jianjun Lv has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Immunology. Recurrent topics in Jianjun Lv's work include Peroxisome Proliferator-Activated Receptors (4 papers), Adipose Tissue and Metabolism (4 papers) and Mitochondrial Function and Pathology (3 papers). Jianjun Lv is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Adipose Tissue and Metabolism (4 papers) and Mitochondrial Function and Pathology (3 papers). Jianjun Lv collaborates with scholars based in China and United States. Jianjun Lv's co-authors include Yang Yang, Shuai Jiang, Tian Li, Wei Hu, Zhiqiang Ma, Zhi Yang, Chongxi Fan, Chao Deng, Zhi Yang and Shouyin Di and has published in prestigious journals such as Circulation Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Jianjun Lv

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianjun Lv China 20 649 210 208 193 183 28 1.4k
Zhenlong Xin China 20 739 1.1× 214 1.0× 96 0.5× 181 0.9× 98 0.5× 27 1.5k
Lora C. Bailey‐Downs United States 14 566 0.9× 371 1.8× 123 0.6× 145 0.8× 89 0.5× 26 1.4k
Qing Peter Wild Zhong United States 23 1.4k 2.1× 263 1.3× 120 0.6× 121 0.6× 156 0.9× 48 2.4k
So Youn Park South Korea 25 624 1.0× 348 1.7× 311 1.5× 226 1.2× 120 0.7× 56 1.6k
Amir Ajoolabady China 23 1.1k 1.6× 258 1.2× 176 0.8× 691 3.6× 110 0.6× 40 2.3k
Tian‐Ying Xu China 23 806 1.2× 435 2.1× 109 0.5× 571 3.0× 278 1.5× 35 1.9k
Vincenzo Sorrentino Switzerland 21 1.1k 1.6× 550 2.6× 89 0.4× 280 1.5× 84 0.5× 33 1.9k
Fiona L. Wilkinson United Kingdom 28 977 1.5× 763 3.6× 278 1.3× 340 1.8× 108 0.6× 59 2.4k

Countries citing papers authored by Jianjun Lv

Since Specialization
Citations

This map shows the geographic impact of Jianjun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Lv more than expected).

Fields of papers citing papers by Jianjun Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Lv. The network helps show where Jianjun Lv may publish in the future.

Co-authorship network of co-authors of Jianjun Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Lv. A scholar is included among the top collaborators of Jianjun Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Lv. Jianjun Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Renyu, C. Li, Ling‐Min Kong, et al.. (2024). UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL. Clinical and Molecular Hepatology. 30(4). 771–792. 10 indexed citations
2.
Lv, Jianjun, et al.. (2022). The effect of visfatin genotype on insulin pump therapy on quality of life in patients with type I diabetes. Cellular and Molecular Biology. 67(4). 195–202. 1 indexed citations
3.
Wang, Changyu, Jianjun Lv, Jiawen Li, et al.. (2022). Novel role of COX6c in the regulation of oxidative phosphorylation and diseases. Cell Death Discovery. 8(1). 336–336. 19 indexed citations
4.
Wang, Hao, Jianjun Lv, Yu Zhao, et al.. (2021). Endothelial genetic deletion of CD147 induces changes in the dual function of the blood‐brain barrier and is implicated in Alzheimer’s disease. CNS Neuroscience & Therapeutics. 27(9). 1048–1063. 9 indexed citations
5.
Lv, Jianjun, Hao Wang, Hong‐Yong Cui, et al.. (2021). Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis. Frontiers in Cell and Developmental Biology. 8. 609090–609090. 9 indexed citations
6.
Lv, Jianjun, Chao Deng, Shuai Jiang, et al.. (2019). Blossoming 20: The Energetic Regulator's Birthday Unveils its Versatility in Cardiac Diseases. Theranostics. 9(2). 466–476. 30 indexed citations
7.
Chen, Qi, Jianjun Lv, Wenwen Yang, et al.. (2019). Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis. Theranostics. 9(22). 6424–6442. 125 indexed citations
8.
Lv, Jianjun, Shuai Jiang, Zhi Yang, et al.. (2018). PGC-1α sparks the fire of neuroprotection against neurodegenerative disorders. Ageing Research Reviews. 44. 8–21. 86 indexed citations
9.
Di, Wencheng, Jianjun Lv, Shuai Jiang, et al.. (2018). PGC-1: The Energetic Regulator in Cardiac Metabolism. Current Issues in Molecular Biology. 28. 29–46. 110 indexed citations
10.
Gu, Chunhu, Tian Li, Shuai Jiang, et al.. (2018). AMP-activated protein kinase sparks the fire of cardioprotection against myocardial ischemia and cardiac ageing. Ageing Research Reviews. 47. 168–175. 57 indexed citations
11.
Li, Tian, Shuai Jiang, Mengzhen Han, et al.. (2018). Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Frontiers in Neuroendocrinology. 52. 22–28. 91 indexed citations
12.
Wang, Shanjie, Yanhong Fan, Xinyu Feng, et al.. (2017). Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1. Biochemical and Biophysical Research Communications. 495(1). 292–299. 37 indexed citations
13.
Zhang, Mingming, Shanjie Wang, Zheng Cheng, et al.. (2017). Polydatin ameliorates diabetic cardiomyopathy via Sirt3 activation. Biochemical and Biophysical Research Communications. 493(3). 1280–1287. 54 indexed citations
14.
Lv, Jianjun, Wei Hu, Zhi Yang, et al.. (2017). Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke. Progress in Neurobiology. 161. 79–96. 121 indexed citations
15.
Di, Shouyin, Chongxi Fan, Liping Cai, et al.. (2016). SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury. APOPTOSIS. 21(8). 905–916. 65 indexed citations
16.
Jiang, Shuai, Yang Yang, Tian Li, et al.. (2016). An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases. Expert Opinion on Therapeutic Targets. 20(12). 1413–1424. 41 indexed citations
17.
Jiang, Shuai, Chao Deng, Jianjun Lv, et al.. (2016). Nrf2 Weaves an Elaborate Network of Neuroprotection Against Stroke. Molecular Neurobiology. 54(2). 1440–1455. 65 indexed citations
18.
Yang, Yang, Song Zhang, Chongxi Fan, et al.. (2016). Protective role of silent information regulator 1 against hepatic ischemia: effects on oxidative stress injury, inflammatory response, and MAPKs. Expert Opinion on Therapeutic Targets. 20(5). 519–531. 22 indexed citations
19.
Zhao, Lin, Chongxi Fan, Yang Yang, et al.. (2016). Adiponectin enhances bone marrow mesenchymal stem cell resistance to flow shear stress through AMP-activated protein kinase signaling. Scientific Reports. 6(1). 28752–28752. 18 indexed citations
20.
Hu, Wei, Yang Yang, Chongxi Fan, et al.. (2016). Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers. APOPTOSIS. 21(6). 675–682. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenlong Xin Breakdown of academic impact, for papers by Lora C. Bailey‐Downs Breakdown of academic impact, for papers by Qing Peter Wild Zhong Breakdown of academic impact, for papers by So Youn Park Breakdown of academic impact, for papers by Amir Ajoolabady Breakdown of academic impact, for papers by Tian‐Ying Xu Breakdown of academic impact, for papers by Vincenzo Sorrentino Breakdown of academic impact, for papers by Fiona L. Wilkinson
Rankless by CCL
2026